Korean J Pediatr.
2013 Jun;56(6):269-269.
Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
- Affiliations
-
- 1Department of Pediatrics, Chungbuk National University, College of Medicine, Cheongju, Korea.
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis
- Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
- Regressed Retinal Astrocytic Hamartomas in Tuberous Sclerosis by Mammalian Target of Rapamycin Inhibitor (Everolimus) Treatment
- Everolimus Treatment and Follow-up in an Infant with Neurological Complication Associated with Tuberous Sclerosis Complex
- A Case of Facial Angiofibromas in Tuberous Sclerosis Treated with Combination of 10,600 nm Carbon Dioxide Fractional Laser, Pin-hole Carbon Dioxide Laser, Vascular Laser and Topical Rapamycin
